Tech Company Financing Transactions

RadioRx Funding Round

On 4/18/2013, RadioRx received $4 million in investment from private investors.

Transaction Overview

Company Name
Announced On
4/18/2013
Transaction Type
Venture Equity
Amount
$3,950,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the offering will be used for general working capital. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
800 W El Camino Real 180
Mountain View, CA 94040
USA
Email Address
Overview
RadioRx's focus is on the development of first-in-class compounds that affect capillary blood flow through the manipulation of cellular and blood levels of the free radical nitric oxide or NO and its downstream signaling pathways.
Profile
RadioRx LinkedIn Company Profile
Social Media
RadioRx Company Twitter Account
Company News
RadioRx News
Facebook
RadioRx on Facebook
YouTube
RadioRx on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Bryan Oronsky
  Bryan Oronsky LinkedIn Profile  Bryan Oronsky Twitter Account  Bryan Oronsky News  Bryan Oronsky on Facebook
VP - R & D
Jan Scicinski
  Jan Scicinski LinkedIn Profile  Jan Scicinski Twitter Account  Jan Scicinski News  Jan Scicinski on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/18/2013: Lagrange Systems venture capital transaction
Next: 4/18/2013: Mytonomy venture capital transaction

 

Share this article

 


Where The Data Comes From

We record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary